Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (SHA:603896)
China flag China · Delayed Price · Currency is CNY
20.68
-0.05 (-0.24%)
Feb 13, 2026, 3:00 PM CST

SHA:603896 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
628.9677.92770.34817.67759.99629.84
Other Revenue
13.7613.7614.0111.47.156.21
642.66691.68784.35829.07767.14636.05
Revenue Growth (YoY)
-10.85%-11.81%-5.39%8.07%20.61%16.33%
Cost of Revenue
125.57133.35135.53129.21126.37105.67
Gross Profit
517.09558.34648.82699.86640.76530.38
Selling, General & Admin
366.18390.75403.79405.17397.19336.38
Research & Development
58.6948.4149.6847.8250.8248.49
Other Operating Expenses
10.59-2.21-4.526.847.675.34
Operating Expenses
434.63436.85447.73461.41456.47390.67
Operating Income
82.46121.49201.09238.45184.3139.71
Interest Expense
-20.04-14.78-24.7-13.03-10.17-11.72
Interest & Investment Income
20.2436.8451.7729.993120.29
Other Non Operating Income (Expenses)
-0.79-0.47-0.43-0.68-0.56-0.5
EBT Excluding Unusual Items
81.86143.08227.72254.73204.57147.79
Gain (Loss) on Sale of Investments
8.144.630.27-1.26-12.33-4.91
Gain (Loss) on Sale of Assets
0.438.810.170.070.03-
Asset Writedown
-0.02-0.02-0.03-0.06-0-0
Other Unusual Items
46.0318.2226.7724.488.7910.83
Pretax Income
136.43174.73254.91277.97201.06153.7
Income Tax Expense
0.120.010.430.450.751.99
Earnings From Continuing Operations
136.31174.71254.48277.51200.31151.71
Minority Interest in Earnings
-0--0.270.52-
Net Income
136.31174.71254.48277.78200.83151.71
Net Income to Common
136.31174.71254.48277.78200.83151.71
Net Income Growth
-40.70%-31.34%-8.39%38.32%32.37%22.45%
Shares Outstanding (Basic)
197199196194191184
Shares Outstanding (Diluted)
197199196194191184
Shares Change (YoY)
0.03%1.42%0.77%1.56%3.77%0.70%
EPS (Basic)
0.690.881.301.431.050.82
EPS (Diluted)
0.690.881.301.431.050.82
EPS Growth
-40.72%-32.31%-9.09%36.19%27.57%21.60%
Free Cash Flow
-36.48-293.62-99.48158.68135.07191.38
Free Cash Flow Per Share
-0.18-1.48-0.510.820.711.04
Dividend Per Share
0.2700.2700.3900.4400.3110.240
Dividend Growth
-30.77%-30.77%-11.36%41.25%29.79%-9.57%
Gross Margin
80.46%80.72%82.72%84.41%83.53%83.39%
Operating Margin
12.83%17.56%25.64%28.76%24.02%21.96%
Profit Margin
21.21%25.26%32.45%33.51%26.18%23.85%
Free Cash Flow Margin
-5.68%-42.45%-12.68%19.14%17.61%30.09%
EBITDA
145.38185.96267.62295.78233.47183.05
EBITDA Margin
22.62%26.88%34.12%35.68%30.43%28.78%
D&A For EBITDA
62.9364.4766.5357.3349.1743.34
EBIT
82.46121.49201.09238.45184.3139.71
EBIT Margin
12.83%17.56%25.64%28.76%24.02%21.96%
Effective Tax Rate
0.09%0.01%0.17%0.16%0.37%1.29%
Revenue as Reported
642.66691.68784.35829.07767.14636.05
Advertising Expenses
-190.46201.21201.3198.54170.35
Source: S&P Global Market Intelligence. Standard template. Financial Sources.